Association of mean platelet volume (MPV), MPV/PLATELET (PLT) ratio, and lymphocyte/ monocyte ratio (LMR) as poor prognostic factor in EGFR-mutant lung adenocarcinoma treated with EGFR tyrosine kinase inhibitor
Tuberk Toraks · 2024
DOI: 10.5578/tt.202403838 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tuberk Toraks, 2024. Verfasst von Hasret Gizem Kurt und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Chest Disease, Private Sincan Koru Hospital, Ankara, Türkiye. Hauptthemen laut MEDLINE: ErbB Receptors, Mean Platelet Volume, Lung Neoplasms, Adenocarcinoma of Lung. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Clinic of Chest Disease, Private Sincan Koru Hospital, Ankara, Türkiye.
- Clinic of Chest Disease, Atatürk Sanatorium Training and Research Hospital, Ankara, Türkiye.
- Department of Medical Patology, Gazi University Faculty of Medicine, Ankara, Türkiye.
Zitieren
APA
Kurt, H. G., Akinci Özyürek, B., Erdoğan, Y., & Akyürek, N. (2024). Association of mean platelet volume (MPV), MPV/PLATELET (PLT) ratio, and lymphocyte/ monocyte ratio (LMR) as poor prognostic factor in EGFR-mutant lung adenocarcinoma treated with EGFR tyrosine kinase inhibitor. Tuberk Toraks. https://doi.org/10.5578/tt.202403838
Vancouver
Kurt HG, Akinci Özyürek B, Erdoğan Y, Akyürek N. Association of mean platelet volume (MPV), MPV/PLATELET (PLT) ratio, and lymphocyte/ monocyte ratio (LMR) as poor prognostic factor in EGFR-mutant lung adenocarcinoma treated with EGFR tyrosine kinase inhibitor. Tuberk Toraks. 2024. doi:10.5578/tt.202403838
BibTeX
@article{Kurt2024,
author = {Kurt, Hasret Gizem and Akinci Özyürek, Berna and Erdoğan, Yurdanur and Akyürek, Nalan},
title = {Association of mean platelet volume (MPV), MPV/PLATELET (PLT) ratio, and lymphocyte/ monocyte ratio (LMR) as poor prognostic factor in EGFR-mutant lung adenocarcinoma treated with EGFR tyrosine kinase inhibitor},
journal = {Tuberk Toraks},
year = {2024},
doi = {10.5578/tt.202403838}
}
EUVIMED